Sean Wieland
Stock Analyst at Piper Sandler
(1.91)
# 3,276
Out of 5,105 analysts
31
Total ratings
45.45%
Success rate
2.68%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $43.86 | +25.40% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $24.91 | +44.52% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $4.61 | +2,503.04% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $37.21 | -83.88% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $43.85 | +0.34% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $222.26 | +3.93% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.55 | +3,754.30% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $43.86
Upside: +25.40%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $24.91
Upside: +44.52%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $4.61
Upside: +2,503.04%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $37.21
Upside: -83.88%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $43.85
Upside: +0.34%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $222.26
Upside: +3.93%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.55
Upside: +3,754.30%